GEP19991514B - Method for Treatment with Interferon - Google Patents

Method for Treatment with Interferon

Info

Publication number
GEP19991514B
GEP19991514B GEAP19932250A GEAP1993002250A GEP19991514B GE P19991514 B GEP19991514 B GE P19991514B GE AP19932250 A GEAP19932250 A GE AP19932250A GE AP1993002250 A GEAP1993002250 A GE AP1993002250A GE P19991514 B GEP19991514 B GE P19991514B
Authority
GE
Georgia
Prior art keywords
interferon
treatment
ifn
consensus
con
Prior art date
Application number
GEAP19932250A
Inventor
Taylor Milton
Blatt Lawrence
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority to GEAP19932250A priority Critical patent/GEP19991514B/en
Publication of GEP19991514B publication Critical patent/GEP19991514B/en

Links

Abstract

1. Technical Result Reduction of side effects. 2. Essence Administering to a patient in need thereof a therapeutically effective amount of consensus (IFN-con) human leukocyte interferon. 3. Field of Application Medicine.
GEAP19932250A 1993-04-14 1993-04-14 Method for Treatment with Interferon GEP19991514B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAP19932250A GEP19991514B (en) 1993-04-14 1993-04-14 Method for Treatment with Interferon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAP19932250A GEP19991514B (en) 1993-04-14 1993-04-14 Method for Treatment with Interferon

Publications (1)

Publication Number Publication Date
GEP19991514B true GEP19991514B (en) 1999-03-05

Family

ID=81852161

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19932250A GEP19991514B (en) 1993-04-14 1993-04-14 Method for Treatment with Interferon

Country Status (1)

Country Link
GE (1) GEP19991514B (en)

Similar Documents

Publication Publication Date Title
TW265265B (en)
GEP20002146B (en) Therapeutic Peptide Derivatives
GEP20002142B (en) Method for Treatment and Prevention of TNF Mediated Diseases
IL134345A0 (en) Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon
MY129244A (en) Combination therapy comprising ribavirin and interferon alpha in antiviral treatment naive patients having chronic hepatitis c infection.
MY117781A (en) Combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
HU9300636D0 (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
ZA913282B (en) Dosage form
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
GEP19991514B (en) Method for Treatment with Interferon
NZ268039A (en) Use of efaroxan in treating parkinson's disease
AU7373196A (en) Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
MY119359A (en) Use of consensus interferon for reducing the side effects of interferon treatment in viral hepatitis.
NO952212D0 (en) Preparations containing acyclovir-like compounds and 2'-vinyl-substituted nucleoside analogues for the treatment of viral infections
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
MY111342A (en) Method and composition for treatment of patients having decompensated liver disease
UA11276C2 (en) Method for rehabilitation of patients after viral hepatitis
UA19596A (en) Method for hypertension desease treatment by hirudoreflexotherapy
RU96104613A (en) METHOD FOR TREATING PATIENTS WITH ENDOCRINE OPHTHALMopathy